In its third quarter results of 2024, pharmaceutical giant GSK confirmed it would pay a quarterly dividend of 15 pence. However, Morningstar analyst Christopher Johnson says he believes that GSK’s ...

GSK’s Arexvy has received expanded approval in Canada for preventing RSV-related lower respiratory tract disease in adults ...

GlaxoSmithKline Pharmaceuticals and Sasken Technologies have released their financial results for the quarter that ended on ...

Pharmaceutical and agricultural companies are among the industry groups pushing against a proposed levy on their returns from ...

The financial regulator has sent warning letters to 10 manufacturers ... Boehringer Ingelheim, GSK, Novartis, Teva, and Covis Pharma have been taken to task for asthma and COPD inhalers, while ...

(Continued from "Pharma news highlights: court cases, controversy and increased transparency efforts") Unarguably, the most sensational item over the past few weeks has been the GlaxoSmithKline ...

The continent is being drenched in an avalanche of medical disinformation with the aim of undermining western influence ...

Report on how AI is redefining market landscape - The global gastroparesis drugs market  size is estimated to grow by USD 1.42 billion from 2024-2028, according to Technavio. The market is estimated ...

China’s probe into AstraZeneca Plc has reached its uppermost echelons, ensnaring local president Leon Wang and throwing into question the future of the most successful Western pharmaceutical company ...

In order to compute the Growth Score and assign it a letter grade ... quality and EPS revisions. GSK plc (GSK) Competitors Companies similar to GSK plc in the Pharmaceuticals industry. You can use the ...